semaglutide fda update Novo Nordisk has announced that the has approved the Wegovy® pill (once-daily oral 25 mg) as the first ever oral GLP-1 receptor agonist therapy for chronic weight management in adults FDA Approves Wegovy Weight-Loss Pill

The condition used to be called Globus hystericus, because doctors thought that people complaining of this sensation were hysterical

The GIPR gene variant rs1800437 variant rs6923761 affect how sensitive your receptors are to the medication, meaning some patients experience mild nausea while others struggle significantly during dose escalation

Theres enough evidence available that these drugs have strong meaningful weight loss, that the side effect profiles are generally ok for the vast majority of individuals

We can price match prescription products sold by CIPA (Canadian International Pharmacy Association) approved companies